Carvedilol
Carvedilol is listed in the FDA National Drug Code directory with 190 NDC codes, marketed under brand names including Carvedilol, Coreg. Available dosage forms: tablet, film coated, powder.
Drug details
- Generic Name
- Carvedilol
- Brand Names
- Carvedilol, Coreg
- Application Number
- ANDA077614
- Sponsor
- Quallent Pharmaceuticals Health LLC
- NDC Codes
- 190
- Dosage Forms
- TABLET, FILM COATED, POWDER
- Routes
- ORAL
- Active Ingredients
- CARVEDILOL
Indications and Usage
1. INDICATIONS AND USAGE . Carvedilol tablets are an alpha/beta-adrenergic blocking agent indicated for the treatment of: mild to severe chronic heart failure ( 1.1 ) left ventricular dysfunction following myocardial infarction in clinically stable patients ( 1.2 ) hypertension ( 1.3) 1.1 Heart Failure Carvedilol tablets are indicated for the treatment of mild-to-severe chronic heart failure of ischemic or cardiomyopathic origin, usually in addition to diuretics, ACE inhibitors, and digitalis, to increase survival and, also, to reduce the risk of hospitalization [ see Drug Interactions ( 7.4 ), Clinical Studies ( 14.1 ) ]. 1.2 Left Ventricular Dysfunction following Myocardial Infarction Carvedilol tablets are indicated to reduce cardiovascular mortality in clinically stable patients who have survived the acute phase of a myocardial infarction and have a left ventricular ejection fraction of less than or equal to 40% (with or without symptomatic heart failure) [see Clinical Studies ( 14.2 )] 1.3 Hypertension Carvedilol tablets are indicated for the management of essential hypertension [ see Clinical Studies ( 14.3 , 14.4 )]. It can be used alone or in combination with other antihypertensive agents, especially thiazide-type diuretics [ see Drug Interactions ( 7.2 )].